United States Antimony (UAMY) moved back into focus after releasing a new technical report on its Fostung tungsten project in Ontario. The report confirms a large skarn-type deposit with associated molybdenum, copper, and silver.
See our latest analysis for United States Antimony.
Despite the excitement around Fostung, the stock has cooled in the short term, with a 1 day share price return of a 4.67% decline and a 30 day share price return of a 20.46% decline. This comes even as the year to date share price return of 40.98% and 1 year total shareholder return of 199.64% point to strong longer term momentum and shifting expectations around the company’s critical minerals potential and project risks.
If Fostung has you thinking more broadly about critical metals, this is a good moment to scan other rare earth related names using our 27 best rare earth metal stocks
So with UAMY sliding recently despite its Fostung update, yet still carrying a year to date gain and a value score of 1, are you looking at an overlooked critical metals play or a stock where markets already price in future growth?
Most Popular Narrative: 34% Undervalued
With United States Antimony last closing at $8.36 against a narrative fair value of $12.67, the current price sits well below what this widely followed model suggests, setting up a valuation story that leans heavily on future growth, margins, and government linked projects.
The company is in late-stage discussions with U.S. government agencies (including DoD and DLA) regarding critical mineral offtake and funding. Any resulting contracts or incentives would provide long-term, recurring, premium-priced revenue and earnings, leveraging the strategic value of being the only domestic antimony processor as U.S. policy shifts toward supply chain security and China de-risking.
Curious what kind of revenue ramp, margin shift, and future earnings multiple are baked into that fair value? The core assumptions tie together aggressive top line growth with a profitability profile and valuation usually reserved for much larger names. The gap between today’s loss making reality and those forward numbers is where this entire thesis lives.
Result: Fair Value of $12.67 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you also need to factor in real execution risks, including permitting delays in Alaska and Ontario, and the possibility that expected federal funding or contracts do not materialise.
Find out about the key risks to this United States Antimony narrative.
Another Way To Look At Value
The popular narrative frames UAMY as 34% undervalued, yet the current P/S ratio of 30.5x tells a very different story. That is far above the US Metals and Mining industry at 2.6x, the peer average of 7.5x, and even the 6x fair ratio that the market could eventually lean toward. For you, that big gap raises a simple question: is this growth story strong enough to justify such a premium, or is sentiment already running ahead of the fundamentals?
To see how those valuation gaps stack up against detailed ratio work and peers, take a look at our breakdown with the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of optimism and caution running through this story, use the data to pressure test your own thesis and act before sentiment shifts, starting with the 2 key rewards and 3 important warning signs.
Looking for more investment ideas?
If UAMY has sharpened your focus on where risk and reward meet, do not stop here. Widen your watchlist before the next move passes you by.
- Target potential mispricings by scanning companies that screen as 59 high quality undervalued stocks and see which ones deserve a spot on your radar.
- Strengthen your income focus by checking out stocks in the 11 dividend fortresses and see which yields line up with your risk comfort.
- Reduce surprises by concentrating on businesses highlighted in the 72 resilient stocks with low risk scores so you can focus on ideas that match your tolerance.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com